BRIEF-Lilly and Astrazeneca receive FDA fast track designation for AZD3293 By: Reuters: Company News August 22, 2016 at 06:18 AM EDT * Lilly and Astrazeneca receive FDA fast track designation for AZD3293, an investigational treatment for early Alzheimer's disease Read More >> Related Stocks: Astrazeneca Plc ADR Eli Lilly